Which Medical Store Franchise Is Best in India? (2026 Comparison)

Last updated: July 30, 2026

There is no single best medical store franchise for everyone — the right one depends on your budget, whether you want to actively run the shop or just fund it, and which city you're opening in. For a first-time owner with roughly ₹10 lakh who wants to actively run their own store and keep the full profit, a zero-royalty FOFO franchise fits better than a large branded chain. For someone with ₹15-30 lakh chasing metro brand recognition, Apollo or MedPlus fits better. This article breaks down the real numbers so you can match the model to your situation, not a marketing pitch.

What Actually Makes One Franchise Better Than Another

The best pharmacy franchise is the one where your total five-year cost — not just the entry price — leaves you with the most profit for the risk you're taking. Four factors decide that: the upfront investment, whether there's an ongoing royalty or revenue share, how much of the licensing and setup work is actually done for you, and how transparently the company shows its real numbers before you sign.

Most comparisons stop at brand recognition. That's the wrong starting point. A big, trusted name doesn't help your monthly profit if a percentage of every sale is contractually owed back to the company for the life of the agreement. Nikhil Chopra, CEO of Wellness Forever, has spoken publicly about how the organised pharmacy retail sector's advantage over kirana-style medical stores is consistency and supply chain — not necessarily individual franchisee margins, which is a distinction worth separating in your own decision.

Royalty vs Zero-Royalty: The Number That Changes Everything

A royalty franchise charges a percentage of your monthly sales or profit on top of what you already paid to open. A zero-royalty franchise charges once, and after that, the store's profit is entirely yours.

Run the actual math before comparing sticker prices. A store doing ₹15 lakh in annual revenue under a 5% royalty pays ₹75,000 a year — ₹3,75,000 over five years — to the franchise company, on top of the original investment. A zero-royalty franchise at a similar or lower entry cost keeps that entire amount with the owner instead. This is the single biggest structural difference between franchise models, and it's rarely the headline number a franchise leads with.

AKTICON runs the zero-royalty FOFO model: a one-time ₹10 lakh fee covering branding, 150 sq. ft. interior fit-out, drug license and pharmacist arrangement, initial stock, and a marketing launch — with nothing owed back afterward.

How the Major Players Compare

Apollo, India's largest pharmacy chain with over 5,000 stores, and MedPlus, with more than 3,700 stores as of late 2024, dominate on national footprint and negotiating power with suppliers. PharmEasy's FOCO network trades ownership control for a lower entry ticket. Jan Aushadhi Kendra is a different category entirely — a government-empaneled generic medicine outlet, not a private franchise — worth understanding on its own terms below.

Where Jan Aushadhi Kendra Fits Into the Comparison

Jan Aushadhi Kendra is a government scheme run by the Department of Pharmaceuticals, not a private franchise brand, and it's worth ruling in or out early since it often shows up in the same searches. It sells generic medicines at 50-90% below branded prices, stocks over 2,110 medicines and 315 surgical items, and has posted year-on-year sales growth above 30% in both FY 2023-24 and FY 2024-25, with cumulative citizen savings crossing ₹30,000 crore by late 2024.

The trade-off: renewal depends on maintaining at least 200 high-velocity medicines and passing government compliance checks, unit margins on generics are thinner than a private pharmacy's broader product mix, and you're operating within a government framework rather than building an independent, brandable local business. It's a genuinely low-cost entry point, but it's a different business model than a private medical store franchise, not a cheaper version of the same thing.

Why Tier 2/3 Cities Change the Calculation

This is the part most "which franchise is best" comparisons skip, and it matters more than almost anything else here: over 60% of new franchise store openings in India are now projected to land in Tier 2 and Tier 3 cities, with these cities driving over 45% of the country's GDP growth. Urban metro pharmacy retail is increasingly saturated; towns between 50,000 and 5 lakh people remain genuinely under-served by organised pharmacy retail.

In that context, national brand recognition — Apollo or MedPlus's biggest advantage — matters less than being the nearest, reliably-stocked, trusted local store. This is exactly the market AKTICON is built around, currently live across Bihar, Jharkhand, Odisha, West Bengal, Madhya Pradesh, Uttar Pradesh, and Rajasthan, where local trust consistently outperforms brand prestige in driving footfall.

What to Check Before Signing Anything

1. Ask for the full cost breakdown in writing — a real term sheet, not a rounded number.
2. Ask exactly what's included: is the drug license fee in there, or billed separately? Is a pharmacist arranged, or is that your responsibility?
3. Ask whether there's any royalty, revenue share, or renewal fee — and get the exact percentage.
4. Ask to see real, currently-operating stores, not renders or a pitch deck.
5. Confirm the shop size and location requirements match what you actually have available.

A franchise that answers all five clearly, before you've paid anything, is telling you something about how it treats partners after you sign. One that stays vague is telling you something too. For the exact line-item numbers behind a transparent quote, see how a medical store franchise's cost actually breaks down.

FAQ

Is a bigger brand always the safer financial choice? Not necessarily. Brand size reduces the risk of the parent company failing, but it doesn't reduce your personal financial exposure if the investment is high and a royalty is reducing your monthly margin indefinitely. For an individual owner, transparency and fit matter more than logo recognition.

Is Jan Aushadhi Kendra cheaper than a private franchise like AKTICON? Entry cost is typically lower, since it's a government-subsidised scheme rather than a full private retail setup. But it's a narrower generic-medicine model with thinner unit margins and stricter inventory compliance requirements, not a direct substitute for a full-range private medical store.

Can I switch franchise models later if I choose wrong? Technically, but it's expensive — you'd likely lose your initial investment, re-license under a new brand, and rebuild local trust from scratch. This is why comparing thoroughly before signing matters more than trying to "test and switch."

Does franchise size guarantee better supplier pricing? Generally yes for bulk-purchasing power, though how much of that saving reaches an individual franchisee's margin — versus being absorbed into franchise fees — varies by brand and agreement.

TL;DR

There's no universal "best" — a metro investor with ₹30 lakh and appetite for an ongoing royalty has different needs than a first-time owner in a Tier 2/3 city with ₹10 lakh who wants full profit retention. Run the five-year cost math, not just the entry price, before choosing. See also: What Is a Pharma Franchise Company?, FOFO vs FOCO: Which Model Makes You More Money, and Top Pharmacy Franchise Options in India, Compared.

About the Author

Om Raj Swatantra — Founder, Acuminex

Om Raj Swatantra is the founder of Acuminex, a growth marketing partner, and works directly on AKTICON LABORATORIES' franchise growth strategy across its operating states.

Acuminex • acuminex.com

Sources

• Apollo Pharmacy Franchise Cost, Investment & ROI
• PharmEasy Franchise Stores
• Jan Aushadhi Kendra Franchise Guide 2026
• Bridging The Pharma Divide: Jan Aushadhi Kendras vs Private Pharmacies
• Why Tier-2 and Tier-3 Cities Are the Next Big Market for Pharma Franchises
• India Retail Pharmacy Market Size, Growth, Share and Forecast